user

Phase II study of induction gemcitabine and S-1 followed by chemoradiotherapy and systemic chemotherapy using S-1 for locally advanced pancreatic cancer

被引：0
|
作者：
Kentaro Sudo
Ryusuke Hara
Kazuyoshi Nakamura
Emiri Kita
Akiko Tsujimoto
Taketo Yamaguchi
机构：
[1] Chiba Cancer Center,Department of Gastroenterology
[2] Chiba Cancer Center,Department of Radiation Oncology
来源：
Cancer Chemotherapy and Pharmacology | 2017年 / 80卷
关键词：
Pancreatic cancer; Gemcitabine; S-1; Chemoradiotherapy; Induction chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：195 / 202
页数：7
相关论文
共 50 条
  • [21] S-1 plus gemcitabine chemotherapy followed by concurrent radiotherapy and maintenance therapy with S-1 for unresectable pancreatic cancer
    Qing-Hua Ke
    Shi-Qiong Zhou
    Ji-Yuan Yang
    Wei Du
    Gai Liang
    Yong Lei
    Fei Luo
    World Journal of Gastroenterology, 2014, (38) : 13987 - 13992
  • [22] Phase II study of S-1 in patients with gemcitabine-resistant advanced pancreatic cancer
    Kentaro Sudo
    Taketo Yamaguchi
    Kazuyoshi Nakamura
    Tadamichi Denda
    Taro Hara
    Takeshi Ishihara
    Osamu Yokosuka
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 249 - 254
  • [23] Phase II study of S-1 in patients with gemcitabine-resistant advanced pancreatic cancer
    Sudo, Kentaro
    Yamaguchi, Taketo
    Nakamura, Kazuyoshi
    Denda, Tadamichi
    Hara, Taro
    Ishihara, Takeshi
    Yokosuka, Osamu
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (02) : 249 - 254
  • [24] A phase II study of gemcitabine, erlotinib, and S-1 in patients with advanced pancreatic cancer.
    Han, Boram
    Kim, Hyeong Su
    Choi, Dae Ro
    Shim, Byoungyong
    Lee, Kyung Hee
    Kim, Jin Won
    Kim, Jung Han
    Kim, Jung Hoon
    Song, Hunho
    Park, Choong Kee
    Moon, Sung Hoon
    Kim, Jong Hyeok
    Jeon, Jang Yong
    Lee, Jung Woo
    Zang, Dae Young
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [25] Randomized phase II study of S-1 and concurrent radiotherapy with versus without induction chemotherapy of gemcitabine for locally advanced pancreatic cancer (JCOG1106)
    Fukutomi, Akira
    Mizusawa, Junki
    Katayama, Hiroshi
    Nakamura, Satoaki
    Ito, Yoshinori
    Hiraoka, Nobuyoshi
    Ioka, Tatsuya
    Ueno, Makoto
    Ikeda, Masafumi
    Sugimori, Kazuya
    Shimizu, Kyoko
    Okusaka, Takuji
    Ozaka, Masato
    Yanagimoto, Hiroaki
    Nakamori, Shoji
    Azuma, Takeshi
    Hosokawa, Ayumu
    Sata, Naohiro
    Mine, Tetsuya
    Furuse, Junji
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [26] A phase II study of adjuvant S-1/cisplatin chemotherapy followed by S-1-based chemoradiotherapy in advanced gastric cancer.
    Shim, H.
    Bae, W. K.
    Hwang, J.
    Yoon, J.
    Yang, D. H.
    Nam, T.
    Ryu, S.
    Park, Y.
    Chung, I.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [27] S-1 IN COMBINATION WITH GEMCITABINE FOR ADVANCED PANCREATIC CANCER
    Sudo, K.
    Yamaguchi, T.
    Nakamura, K.
    Hara, T.
    Ishihara, T.
    Denda, T.
    ANNALS OF ONCOLOGY, 2008, 19 : 185 - 185
  • [28] The Role of Gemcitabine/S-1 in the Neoadjuvant Setting for Locally Advanced Pancreatic Cancer
    Kinoshita, S.
    Sho, M.
    Takahiro, A.
    Nomi, T.
    Yamato, I.
    Hokuto, D.
    Yasuda, S.
    Nakajima, Y.
    PANCREAS, 2012, 41 (07) : 1157 - 1157
  • [29] Neoadjuvant Chemoradiation With Gemcitabine and S-1 for Patients With Locally Advanced Pancreatic Cancer
    Kurata, M.
    Honda, G.
    Tsuruta, K.
    Kamisawa, T.
    Karasawa, K.
    PANCREAS, 2009, 38 (08) : 1020 - 1020
  • [30] A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer
    Do-Youn Oh
    Yongjun Cha
    In-Sil Choi
    So-Young Yoon
    In Keun Choi
    Jee Hyun Kim
    Sang Cheul Oh
    Chang Duck Kim
    Jae Sun Kim
    Yung-Jue Bang
    Yeul Hong Kim
    Cancer Chemotherapy and Pharmacology, 2010, 65 : 527 - 536
12345